The module is currently available in English, French, Nepali, Portuguese, Russian, and Spanish
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
Working Document, September 2017
Zanoni BC, et al. BMJ Glob Health 2016;1:e000004. doi:10.1136/bmjgh-2015-000004
Promising Approaches to Combination HIV Prevention Programming in Concentrated Epidemics
AIDSTAR-One CASE STUDY SERIES May 2010
Summary Report
Accessed: 19.10.2019
J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
PLoS One. 2012; 7(4): e29656.
Published online 2012 Apr 20. doi: 10.1371/journal.pone.0029656
Federal Bureau of Prisons
Clinical Practice Guidelines
January 1010
PLOS ONE | DOI:10.1371/journal.pone.0142290 November 9, 2015; 1 / 16
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response
to the Sixty-second World Health Assembly’s resolution on prevention and control of multidrug-resistant tuberculosis and e...xtensively drug-resistant tuberculosis.
more
front cover © Hannah Maule-Ffinch/Save the Children